New pill for postpartum depression a vital breakthrough

New pill for postpartum depression a vital breakthrough
One in seven new mothers develop the serious medical condition. (Image: Getty)
Bloomberg
By Lisa Jarvis The landmark approval in the US of the first pill for postpartum depression offers an important new treatment for the 1 in 7 new mothers who develop the condition. Suicide is a leading cause of maternal mortality in the US. And yet on its own, the new drug – promising as it is – isn’t enough. Consider that as many as half of women with postpartum depression go undiagnosed.Nonetheless, the new pill is a remarkable breakthrough, and one of several encouraging recent developments in women’s health &...

More Health

Mainland Capital delivers $50m raise for Chch hospital expansion
Finance

Mainland Capital delivers $50m raise for Chch hospital expansion

The oversubscribed raise will help fund a new state-of-the-art private hospital facility.

Oliver Lewis 13 Jun 2025
Green Cross Health navigates tough year with $16m profit
Markets

Green Cross Health navigates tough year with $16m profit

The company is navigating a 'challenging healthcare landscape'.

John Anthony 29 May 2025
Oceania dividend not expected for 'foreseeable future': Jarden
Property

Oceania dividend not expected for 'foreseeable future': Jarden

The retirement and aged care firm has signalled a change to its dividend policy.

Gregor Thompson 27 May 2025
Health NZ seeks ‘partnerships’ with major health contractors
Policy

Health NZ seeks ‘partnerships’ with major health contractors

The agency is establishing a major projects panel to tackle $6.4b pipeline.

Oliver Lewis 27 May 2025